Pamela Celiz
Sitges
Overview
17
17
years of professional experience
Work History
Medical Oncologist
Instituto Català D'Oncologia
01.2022 - Current
Medical Oncologist
Hospital Del Mar
01.2021 - 02.2022
Scientific Manager/ Medical Manager
SOLTI-Breast Cancer Research Group
01.2017 - 11.2020
Medical Oncologist
Hospital Universitario 12 de Octubre, Madrid
01.2013 - 11.2016
Medical Oncologist
Hospital Germans Trias I Pujol
01.2008 - 03.2012
Education
Fellowship - Urological Tumors
Hospital Universitario 12 De Octubre
Madrid2015
Ph.D. - Medicine
Universidad Autonoma De Barcelona
Barcelona10.2012
Medical Oncologist -
Universidad Católica De Cordoba
Argentina01.2008
Medical Doctor -
Universidad Católica De Córdoba
Argentina01.2003
Postgraduate training
- PhD in Medicine, 2012- Prognostic and predictive factors of response in patients with locally advanced bladder carcinoma treated with neoadjuvant chemotherapy.
- Fellowship in Urological Tumors, 2013-2015, Hospital Universitario 12 de Octubre
Publications
- Font A, Taron M, Gago JL, Costa C, Sánchez JJ, Carrato C, Mora M, Celiz P, Perez L, Rodríguez D, Gimenez-Capitan A, Quiroga V, Benlloch S, Ibarz L, Rosell R. BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer. Ann Oncol. 2011 Jan;22(1):139-144. IF: 7.3
- Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial The Lancet Oncology 2020. 21-1, pp.33-43. IF: 41,3
- Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study. Front Oncol 2021;11;645026. IF: 5,3
- Fort-Casamartina, E., Muñoz-Sanchez, C., Rigo-Bonnin, R.F. et al. First reported double drug–drug interaction in a cancer renal patient under everolimus treatment: therapeutic drug monitoring and review of literature. Eur J Med Res 28, 202 (2023). IF: 4,2
Languages
English
Advanced (C1)
Timeline
Medical Oncologist
Instituto Català D'Oncologia
01.2022 - Current
Medical Oncologist
Hospital Del Mar
01.2021 - 02.2022
Scientific Manager/ Medical Manager
SOLTI-Breast Cancer Research Group
01.2017 - 11.2020
Medical Oncologist
Hospital Universitario 12 de Octubre, Madrid
01.2013 - 11.2016
Medical Oncologist
Hospital Germans Trias I Pujol
01.2008 - 03.2012
Fellowship - Urological Tumors
Hospital Universitario 12 De Octubre
Ph.D. - Medicine
Universidad Autonoma De Barcelona
Medical Oncologist -
Universidad Católica De Cordoba
Medical Doctor -
Universidad Católica De Córdoba